|
2-Chloroadenine (25 mg) (2-Chloro-7H-purin-6-amine) |
1839-18-5 |
1112208 |
USP |
詳細を見る
|
|
Cefoxitin System Suitability Mixture (15 mg) |
N/A |
1098108 |
USP |
詳細を見る
|
|
Carglumic Acid Related Compound D (25 mg) ((S)-1-Carbamoyl-5-oxopyrrolidine-2-c… |
N/A |
1096473 |
USP |
詳細を見る
|
|
Calcitonin Salmon Related Compound B (10 mg) (calcitonin salmon-glycine) (COLD … |
115472-96-3 |
1086222 |
USP |
詳細を見る
|
|
Caffeine Related Compound C (20 mg) (1,3,9-Trimethyl-3,9-dihydro-1H-purine-2,6-… |
519-32-4 |
1086063 |
USP |
詳細を見る
|
|
Caffeine Related Compound D (20 mg) (3,7-Dimethyl-3,7-dihydro-1H-purine-2,6-dio… |
83-67-0 |
1086064 |
USP |
詳細を見る
|
|
Caffeine Related Compound F (20 mg) (1,7-Dimethyl-3,7-dihydro-1H-purine-2,6-dio… |
611-59-6 |
1086066 |
USP |
詳細を見る
|
|
Buprenorphine Related Compound B CII (25 mg) ((S)-2-(4,5alpha-Epoxy-3-hydroxy-6… |
209963-02-0 |
1078697 |
USP |
詳細を見る
|
|
Brivaracetam Related Compound A (15 mg) ((S)-2-[(S)-2-Oxo-4-propylpyrrolidin-1-… |
357336-19-7 |
1078041 |
USP |
詳細を見る
|
|
Brivaracetam Related Compound B (15 mg) ((R)-2-[(S)-2-Oxo-4-propylpyrrolidin-1-… |
357336-99-3 |
1078052 |
USP |
詳細を見る
|
